Further, we show that a METTL3 inhibitor, which has been shown to be effective against acute myeloid leukaemia and in an improved version is currently undergoing clinical trials for solid tumours (identifier NCT05584111) [32], leads to inhibition of all three viruses. This evidence concerns the gene METTL3 and acute myeloid leukemia.